403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
US Health Agency Report on COVID Vaccine Impact Blocked
(MENAFN) According to multiple reports, the US Centers for Disease Control and Prevention (CDC) has declined to publish a scientific report that found COVID-19 vaccination significantly reduced hospitalizations.
The findings reportedly showed that COVID-19 vaccines cut hospital admissions by nearly 50% among adults during the winter of 2026. The study was initially scheduled for publication on March 19, but its release was delayed and later blocked, according to The Washington Post and CNN, which cited individuals familiar with the matter.
A spokesperson for the Department of Health and Human Services, Andrew Nixon, confirmed the decision and said, “Scientific reports are routinely reviewed at multiple levels to ensure they meet the highest standards before publication,” adding that “the manuscript was not accepted for publication.”
He also noted concerns related to the study’s methodology, stating that there were issues with the “methodological approach estimating vaccine effectiveness,” as reported by People.
Nixon further explained that it is standard procedure for CDC leadership to review and flag concerns about papers prepared for the Morbidity and Mortality Weekly Report, particularly when questions arise about methodology prior to publication.
Reports also indicated that Acting CDC Director and National Institutes of Health chief Jay Bhattacharya halted the publication due to methodological concerns, according to The Washington Post. The CDC operates under the Department of Health and Human Services.
The decision comes amid ongoing political debate in the United States surrounding vaccines. Health and Human Services Secretary Robert F. Kennedy Jr., who has long expressed skepticism about vaccines, has repeatedly emphasized “transparency” and “informed choice.” In a March 2025 interview on Fox News, he said: “We should have transparency. We should have informed choice, and if people don't want it, the government shouldn't force them to do it.”
The findings reportedly showed that COVID-19 vaccines cut hospital admissions by nearly 50% among adults during the winter of 2026. The study was initially scheduled for publication on March 19, but its release was delayed and later blocked, according to The Washington Post and CNN, which cited individuals familiar with the matter.
A spokesperson for the Department of Health and Human Services, Andrew Nixon, confirmed the decision and said, “Scientific reports are routinely reviewed at multiple levels to ensure they meet the highest standards before publication,” adding that “the manuscript was not accepted for publication.”
He also noted concerns related to the study’s methodology, stating that there were issues with the “methodological approach estimating vaccine effectiveness,” as reported by People.
Nixon further explained that it is standard procedure for CDC leadership to review and flag concerns about papers prepared for the Morbidity and Mortality Weekly Report, particularly when questions arise about methodology prior to publication.
Reports also indicated that Acting CDC Director and National Institutes of Health chief Jay Bhattacharya halted the publication due to methodological concerns, according to The Washington Post. The CDC operates under the Department of Health and Human Services.
The decision comes amid ongoing political debate in the United States surrounding vaccines. Health and Human Services Secretary Robert F. Kennedy Jr., who has long expressed skepticism about vaccines, has repeatedly emphasized “transparency” and “informed choice.” In a March 2025 interview on Fox News, he said: “We should have transparency. We should have informed choice, and if people don't want it, the government shouldn't force them to do it.”
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment